Insiders Sensei Biotherapeutics, Inc.

Equities

SNSE

US81728A1088

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
1.51 ^USD	-3.82%		-15.64%	+118.21%

05-09	Sensei Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-24	Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sensei Biotherapeutics, Inc. Announces Management Changes	02-08	CI
Sensei Biotherapeutics, Inc. Appoints Stephanie Krebs, Ms, Mba, as Chief Business Officer	11-01	CI
Apeiron Investment Withdraws its Notice of Intent to Nominate Director at Sensei Biotherapeutics	23/05/23	CI
Sensei Biotherapeutics Confirms the Receipt of Nominations from Apeiron Investment Group	10/03/23	CI
Apeiron Investment Nominates Candidates to the Board of Sensei Biotherapeutics	09/03/23	CI
Sensei Biotherapeutics, Inc. Announces Executive Changes	08/12/22	CI
Sensei Biotherapeutics Appoints Patrick Gallagher, MBA, MPH, as Chief Business Officer	01/06/22	CI
Sensei Biotherapeutics, Inc. Appoints William Ringo as Chair of Its Board of Directors and as A Member of Compensation Committee and Nominating and Corporate Governance Committee	09/03/22	CI
Insider Buy: Sensei Biotherapeutics	27/01/22	MT
Insider Buy: Sensei Biotherapeutics	18/01/22	MT
Sensei Biotherapeutics Appoints Erin Colgan as CFO	06/01/22	MT
Sensei Biotherapeutics, Inc. Appoints Erin Colgan as Chief Financial Officer	06/01/22	CI
Sensei Biotherapeutics, Inc. Appoints Robert Pierce as Chief Research & Development Officer	06/01/22	CI
Faron Pharmaceuticals Names New Chief Medical Officer	04/01/22	MT
Finland's Faron Pharmaceuticals Names Chief Medical Officer	03/01/22	MT
Insider Buy: Sensei Biotherapeutics	30/12/21	MT
Sensei Biotherapeutics Named a Winner of Comparably’s Best CEO Award	16/12/21	AQ
Sensei Biotherapeutics, Inc. Appoints Kristian Humer as Director and as Member of the its Audit Committee	02/08/21	CI
Sensei Biotherapeutics, Inc. Announces Termination of Employment of Anupama Hoey, Effective as of June 18, 2021	17/06/21	CI
Sensei Biotherapeutics Inc. Announces Advisory Board Appointments	05/05/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SENSEI BIOTHERAPEUTICS : Mixed Q3; but cash cushion remains intact

November 10, 2022 at 11:59 am